Naturally-occurring anti-Jka in infant twins
نویسندگان
چکیده
منابع مشابه
Naturally occurring ehrlichiosis in Egyptian dogs
Canine ehrlichiosis has emerged as one of the most clinically important tick-borne diseases affecting dogs. Eighty-five naturally infected dogs have been investigated, the most consistent clinical signs recorded were fever, emaciation and lymphoadenopathy, anemia, monocytosis, thrompocytopenia, hypoalbuminemia, elevation in liver enzymes and total bilirubin were the most remarkable changes asso...
متن کاملNaturally occurring anti-cancer agents targeting EZH2.
Natural products are considered as promising tools for the prevention and treatment of cancer. The enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase unit of polycomb repressor complexes such as PRC2 complex that has oncogenic roles through interference with growth and metastatic potential. Several agents targeting EZH2 has been discovered but they often induce side effects in cl...
متن کاملAnti-C as a naturally-occurring antibody.
IT IS accepted generally that antibodies directed against red blood cell antigens in the Rh system result from isoimmunization either by transfusion or pregnancy and rarely can be considered “naturally-occurring.” Diamond et al. reported the first example of a naturally-occurring antibody within this system in 1942.3 They described an antibody, apparently anti-D, in the serum of a five-year-old...
متن کاملMyasthenia gravis occurring in twins.
Myasthenia gravis in one member each of two sets of twins is described. A 17 year old girl developed generalized myasthenia gravis at the age of 14 years, while her monozygotic twin sister has remained in good health during a three year period of observation. Another patient was a 19 year old woman with the onset of generalized myasthenia gravis at the age of 11 years, and her dizygotic twin si...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Immunohematology
سال: 2020
ISSN: 0894-203X,1930-3955
DOI: 10.21307/immunohematology-2019-638